Mark E. Saad - Insider Trading & Ownership

Entity
Individual
Location
C/O Cytori Therapeutics, Inc., 3020 Callan Road, San Diego, CA
Summary
The estimated net worth of Mark E. Saad is at least $941K dollars as of September 11, 2024. Mark E. Saad is the Director of Axsome Therapeutics, Inc. and owns shares of Axsome Therapeutics, Inc. (AXSM) stock worth about $941K.
All Insider Reports
All Insider Reports

Ownership of Mark E. Saad

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AXSM Axsome Therapeutics, Inc. Director $941K -$1.01M -51.7% Sep 11, 2024

Insider Transactions Reported by Mark E. Saad:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.